APA-Zitierstil (7. Ausg.)

Döhner, H., Lübbert, M., Fiedler, W., Fouillard, L., Haaland, A., Brandwein, J. M., . . . Maertens, J. (2014). Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy. Blood, 124(9), . https://doi.org/10.1182/blood-2014-03-560557

Chicago-Zitierstil (17. Ausg.)

Döhner, Hartmut, et al. "Randomized, Phase 2 Trial of Low-dose Cytarabine with or Without Volasertib in AML Patients Not Suitable for Induction Therapy." Blood 124, no. 9 (2014). https://doi.org/10.1182/blood-2014-03-560557.

MLA-Zitierstil (9. Ausg.)

Döhner, Hartmut, et al. "Randomized, Phase 2 Trial of Low-dose Cytarabine with or Without Volasertib in AML Patients Not Suitable for Induction Therapy." Blood, vol. 124, no. 9, 2014, https://doi.org/10.1182/blood-2014-03-560557.